
NASDAQ:SBRA
This summary was created by AI, based on 1 opinions in the last 12 months.
Sabra Health Care REIT (SBRA-Q) is being favorably recognized by experts, with strong endorsements highlighting its strategic position in the nursing, retirement, and behavioral health sectors. Trading at 12x FFO, which is significantly lower than the broader market average, it offers an attractive dividend yield of 6.5%. The company is experiencing tailwinds from demographic trends and is projected to see earnings grow by 5.5% this year. Additionally, having gained 17% in the past year, Sabra demonstrates solid momentum alongside its fundamental strength. Experts believe that, rather than being adversely affected by advancements in AI, Sabra could leverage these innovations to enhance its operations and service delivery.
Sabra Health Care REIT is a American stock, trading under the symbol SBRA (previously SBRA-Q on Stockchase) on the NASDAQ (SBRA). It is usually referred to as NASDAQ:SBRA or SBRA
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SBRA (previously SBRA-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is STRONG BUY. Read the latest stock experts' ratings for Sabra Health Care REIT.
Sabra Health Care REIT was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sabra Health Care REIT.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sabra Health Care REIT.
Sabra Health Care REIT is followed by 6 investors on Stockchase and is a trending stock that is worth watching.
On 2026-08-13, Sabra Health Care REIT (SBRA) stock closed at a price of $20.15.
Her top pick of 2026. Trades at 12x FFO, half the market's, and pays a 6.5% dividend. They are in the nursing space (retirement and skilled), and behavioural health. Enjoys demographic winds. Earnings to grow 5.5% this year. Up 17% last year, so has momentum as well as fundamentals. Is not threatened by AI, and could even benefit Sabra.